Clara M. Cambria
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
CRISPR/Cas9-mediated PHOX2B functional knock-out in IMR32 neuroblastoma cells impairs neuronal excitability through dysregulation of ion channels genes.
Journal: Frontiers in physiology
Published: March 31, 2026
Connexin hemichannel blockade by abEC1.1 disrupts glioblastoma progression, suppresses invasiveness, and reduces hyperexcitability in preclinical models.
Journal: Cell communication and signaling : CCS
Published: April 03, 2025
Loss of PLA2G4E compromises synaptic structure and cognitive outcomes in mice.
Journal: Life science alliance
Published: March 25, 2025
Neuronal PCSK9 regulates cognitive performances via the modulation of ApoER2 synaptic localization.
Journal: Pharmacological research
Published: December 20, 2024
Exome sequencing reveals a rare damaging variant in GRIN2C in familial late-onset Alzheimer's disease.
Journal: Alzheimer's research & therapy
Published: July 10, 2024
Neural precursor cells rescue symptoms of Rett syndrome by activation of the Interferon γ pathway.
Journal: EMBO molecular medicine
Published: January 07, 2024
Glucose-derived glutamate drives neuronal terminal differentiation in vitro.
Journal: EMBO reports
Published: July 13, 2023
Loss of CDKL5 Causes Synaptic GABAergic Defects That Can Be Restored with the Neuroactive Steroid Pregnenolone-Methyl-Ether.
Journal: International journal of molecular sciences
Published: November 02, 2022
ATM rules neurodevelopment and glutamatergic transmission in the hippocampus but not in the cortex.
Journal: Cell death & disease
Published: July 12, 2021
LSD1 is an environmental stress-sensitive negative modulator of the glutamatergic synapse.
Journal: Neurobiology of stress
Published: August 15, 2020
Last Updated: 09/26/2026